HomeInsightsMarket Capitalization

Market Capitalization of Gland Pharma Ltd

Market Capitalization of Gland Pharma Ltd

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Dec 4, 2024)

stocks purchased

4.9 K

Stocks Traded

(Dec 4, 2024)

Last Updated on: Dec 05, 2024

Image

Gland Pharma Ltd

NSE: GLAND

Market Cap

₹ 29661.9 crore

Last updated on: Dec 04, 2024

Key Highlights

  • The Market Cap of Gland Pharma Ltd is ₹ 29661 crore as of 04 Dec 24 .
  • The Market Cap of Gland Pharma Ltd changed from ₹ 40535 crore on March 2021 to ₹ 30338 crore on March 2024 . This represents a CAGR of -6.99% over 4 years.
  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1800 as of 04 Dec 15:30 .
  • The Dividend Payouts of Gland Pharma Ltd is ₹ 20 as of Aug 16, 2024 .

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Gland Pharma Ltd

No data available

Image

Gland Pharma Ltd

NSE: GLAND

Share Price

₹ 1800.4

-13.35 (-0.74%)

stock direction

Last updated on: Dec 04, 2024

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Dec 20241800.4
03 Dec 20241813.75
02 Dec 20241779.4
29 Nov 20241739.1
28 Nov 20241718.1
27 Nov 20241729.9
26 Nov 20241739.85
25 Nov 20241776.1
22 Nov 20241756.55
21 Nov 20241788.5

SWOT Analysis Of Gland Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gland Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Gland Pharma Ltd

No data available

No data available

Historical P/E Ratio of Gland Pharma Ltd

No data available

* All values are in %

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Image

Gland Pharma Ltd

NSE: GLAND

DIVIDENDPAYOUT

₹ 20

Last updated on: Aug 16, 2024

About Gland Pharma Ltd

  • Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994 and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act, 1956.
  • The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.

Gland Pharma Ltd News Hub

News

Gland Pharma rises on USFDA nod for ophthalmic solution

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Dec 2024 11:05

News

Gland Pharma Ltd spurts 1.67%, rises for third straight session

Gland Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1809....

Read more

03 Dec 2024 13:06

News

Gland Pharma soars as Q2 PAT rises 9% QoQ to Rs 282 cr

On a consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore despite ...

Read more

05 Nov 2024 10:42

News

Volumes jump at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Hatsun Agro Product Ltd, ABB India Ltd, Bata India Ltd are among the...

Read more

05 Nov 2024 11:00

News

Volumes soar at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Mangalore Refinery And Petrochemicals Ltd, K E C International Ltd, ...

Read more

05 Nov 2024 14:30

News

Gland Pharma to hold board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 4 November 20...

Read more

23 Oct 2024 10:19

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Gland Pharma Ltd Market Cap

What is the market cap of Gland Pharma Ltd?

As of December 5, 2024, Gland Pharma Ltd has a market capitalization of ₹29661.9, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Gland Pharma Ltd's market capitalization?

Gland Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Gland Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Gland Pharma Ltd's market capitalization change?

Gland Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions